10-Q Filing

UNI-PIXEL CIK: 1171012 Q2 2013

Filing Information

Form Type	10-Q
Accession Number	`0001185185-13-001609`
Period End Date	20130630
Filing Date	20130808
Fiscal Year	2013
Fiscal Period	Q2
XBRL Instance	unxl-20130630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 47 Income Statement 49 Cash Flow Statement 53 Stockholders Equity 23

Balance Sheet 47 line items

Line Item	Tag	Value	Unit	Period
Accumulated depreciation (in Dollars)	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$2.53M	USD	Point-in-time
Accumulated depreciation (in Dollars)	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$3.07M	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$53.41M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$7.22M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$4.63M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$13.00M	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	-	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	9.85M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	12.04M	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$160.32K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$13.16M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$53.41M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	12.04M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	9.85M	shares	Point-in-time
Property and equipment, net of accumulated depreciation of $3,071,386 and $2,531,917, at June 30, 2013 and December 31, 2012, respectively	`PropertyPlantAndEquipmentNet`	$9.85M	USD	Point-in-time
Property and equipment, net of accumulated depreciation of $3,071,386 and $2,531,917, at June 30, 2013 and December 31, 2012, respectively	`PropertyPlantAndEquipmentNet`	$1.54M	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$17.44K	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$17.44K	USD	Point-in-time
Total assets	`Assets`	$63.28M	USD	Point-in-time
Total assets	`Assets`	$14.71M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$348.68K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.29M	USD	Point-in-time
Bonus accrual	`OtherAccruedLiabilitiesCurrent`	-	USD	Point-in-time
Bonus accrual	`OtherAccruedLiabilitiesCurrent`	$273.68K	USD	Point-in-time
Deferred revenue	`DeferredRevenueCurrent`	$5.00M	USD	Point-in-time
Deferred revenue	`DeferredRevenueCurrent`	-	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$6.56M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$348.68K	USD	Point-in-time
Total liabilities	`Liabilities`	$6.56M	USD	Point-in-time
Total liabilities	`Liabilities`	$348.68K	USD	Point-in-time
Commitments and contingencies (Note 3)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 3)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.001 par value; 100,000,000 shares authorized, 12,037,487 shares issued and outstanding at June 30, 2013 and 9,854,268 shares issued and outstanding at December 31, 2012	`CommonStockValue`	$9.85K	USD	Point-in-time
Common stock, $0.001 par value; 100,000,000 shares authorized, 12,037,487 shares issued and outstanding at June 30, 2013 and 9,854,268 shares issued and outstanding at December 31, 2012	`CommonStockValue`	$12.04K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$131.77M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$85.67M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-71.31M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-75.06M	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$8.30M	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$56.72M	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$14.37M	USD	Point-in-time
Total liabilities and shareholders equity	`LiabilitiesAndStockholdersEquity`	$63.28M	USD	Point-in-time
Total liabilities and shareholders equity	`LiabilitiesAndStockholdersEquity`	$14.71M	USD	Point-in-time

Income Statement 49 line items

Line Item	Tag	Value	Unit	Period
Revenue	`SalesRevenueNet`	$749.00	USD	1 Quarter
Revenue	`SalesRevenueNet`	$70.56K	USD	1 Quarter
Revenue	`SalesRevenueNet`	$74.12K	USD	2 Qtrs
Revenue	`SalesRevenueNet`	$5.07M	USD	2 Qtrs
Cost of revenues	`CostOfRevenue`	$25.48K	USD	2 Qtrs
Cost of revenues	`CostOfRevenue`	$3.42K	USD	2 Qtrs
Cost of revenues	`CostOfRevenue`	$24.11K	USD	1 Quarter
Cost of revenues	`CostOfRevenue`	$385.00	USD	1 Quarter
Gross margin	`GrossProfit`	$364.00	USD	1 Quarter
Gross margin	`GrossProfit`	$5.07M	USD	2 Qtrs
Gross margin	`GrossProfit`	$46.45K	USD	1 Quarter
Gross margin	`GrossProfit`	$48.65K	USD	2 Qtrs
Selling, general and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$2.17M	USD	1 Quarter
Selling, general and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$888.80K	USD	1 Quarter
Selling, general and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$4.35M	USD	2 Qtrs
Selling, general and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$1.82M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$2.32M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$4.47M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$2.53M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$1.20M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-4.70M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-3.75M	USD	2 Qtrs
Operating loss	`OperatingIncomeLoss`	$-2.04M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-4.09M	USD	2 Qtrs
Interest income (expense), net	`InterestExpense`	$-1.25K	USD	1 Quarter
Interest income (expense), net	`InterestExpense`	$-2.83K	USD	2 Qtrs
Interest income (expense), net	`InterestExpense`	$-5.48K	USD	1 Quarter
Interest income (expense), net	`InterestExpense`	$-6.47K	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-9.02M	USD	Annual
Net loss	`NetIncomeLoss`	$-2.04M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-3.75M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-4.08M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-4.70M	USD	1 Quarter
Net loss - basic (in Dollars per share)	`EarningsPerShareBasic`	$-0.29	USD	1 Quarter
Net loss - basic (in Dollars per share)	`EarningsPerShareBasic`	$-0.35	USD	2 Qtrs
Net loss - basic (in Dollars per share)	`EarningsPerShareBasic`	$-0.57	USD	2 Qtrs
Net loss - basic (in Dollars per share)	`EarningsPerShareBasic`	$-0.40	USD	1 Quarter
Net loss - diluted (in Dollars per share)	`EarningsPerShareDiluted`	$-0.40	USD	1 Quarter
Net loss - diluted (in Dollars per share)	`EarningsPerShareDiluted`	$-0.29	USD	1 Quarter
Net loss - diluted (in Dollars per share)	`EarningsPerShareDiluted`	$-0.57	USD	2 Qtrs
Net loss - diluted (in Dollars per share)	`EarningsPerShareDiluted`	$-0.35	USD	2 Qtrs
Weighted average number of basic common shares outstanding (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	11.63M	shares	1 Quarter
Weighted average number of basic common shares outstanding (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	7.14M	shares	1 Quarter
Weighted average number of basic common shares outstanding (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	10.85M	shares	2 Qtrs
Weighted average number of basic common shares outstanding (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	7.14M	shares	2 Qtrs
Weighted average number of diluted common shares outstanding (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	10.85M	shares	2 Qtrs
Weighted average number of diluted common shares outstanding (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	7.14M	shares	2 Qtrs
Weighted average number of diluted common shares outstanding (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	11.63M	shares	1 Quarter
Weighted average number of diluted common shares outstanding (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	7.14M	shares	1 Quarter

Cash Flow Statement 53 line items

Line Item	Tag	Value	Unit	Period
Issuance common stock (in Dollars)	`StockIssued1`	$399.63K	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-9.02M	USD	Annual
Net loss	`NetIncomeLoss`	$-2.04M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-3.75M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-4.08M	USD	2 Qtrs
Cashless Exercise of Warrants	`ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised`	505,661.00	shares	2 Qtrs
Net loss	`NetIncomeLoss`	$-4.70M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$252.98K	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$539.47K	USD	2 Qtrs
Restricted stock issuance	`IssuanceOfStockAndWarrantsForServicesOrClaims`	-	USD	2 Qtrs
Restricted stock issuance	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$763.97K	USD	2 Qtrs
Stock compensation expense	`ShareBasedCompensation`	$1.23M	USD	2 Qtrs
Stock compensation expense	`ShareBasedCompensation`	$1.46M	USD	2 Qtrs
Increase in accounts receivable	`IncreaseDecreaseInAccountsReceivable`	-	USD	2 Qtrs
Increase in accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$43.25K	USD	2 Qtrs
Decrease in prepaid assets and other current assets	`IncreaseDecreaseInPrepaidExpense`	-	USD	2 Qtrs
Decrease in prepaid assets and other current assets	`IncreaseDecreaseInPrepaidExpense`	$-160.32K	USD	2 Qtrs
Increase in accounts payable	`IncreaseDecreaseInAccountsPayable`	$67.16K	USD	2 Qtrs
Increase in accounts payable	`IncreaseDecreaseInAccountsPayable`	$940.53K	USD	2 Qtrs
Increase in bonus accrual	`IncreaseDecreaseInOtherAccruedLiabilities`	-	USD	2 Qtrs
Increase in bonus accrual	`IncreaseDecreaseInOtherAccruedLiabilities`	$273.68K	USD	2 Qtrs
Increase in deferred revenue	`IncreaseDecreaseInOtherDeferredLiability`	-	USD	2 Qtrs
Increase in deferred revenue	`IncreaseDecreaseInOtherDeferredLiability`	$5.00M	USD	2 Qtrs
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-2.57M	USD	2 Qtrs
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$5.39M	USD	2 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$14.07K	USD	2 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$8.86M	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-8.86M	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-14.07K	USD	2 Qtrs
Proceeds from exercise of warrants, net	`ProceedsFromWarrantExercises`	-	USD	2 Qtrs
Proceeds from exercise of warrants, net	`ProceedsFromWarrantExercises`	$151.98K	USD	2 Qtrs
Proceeds from exercise of stock options, net	`ProceedsFromStockOptionsExercised`	-	USD	2 Qtrs
Proceeds from exercise of stock options, net	`ProceedsFromStockOptionsExercised`	$2.50M	USD	2 Qtrs
Proceeds from the issuance of common stock, net	`ProceedsFromIssuanceOfCommonStock`	-	USD	2 Qtrs
Proceeds from the issuance of common stock, net	`ProceedsFromIssuanceOfCommonStock`	$41.22M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$43.87M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	-	USD	2 Qtrs
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-2.59M	USD	2 Qtrs
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$40.41M	USD	2 Qtrs
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$13.00M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$4.63M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$53.41M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$7.22M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$53.41M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$7.22M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$4.63M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$13.00M	USD	Point-in-time
Cash paid for interest	`InterestPaid`	-	USD	2 Qtrs
Cash paid for interest	`InterestPaid`	-	USD	2 Qtrs
Cash paid for income taxes	`IncomeTaxesPaid`	-	USD	2 Qtrs
Cash paid for income taxes	`IncomeTaxesPaid`	-	USD	2 Qtrs
Issuance of 399,629 shares of common stock in exchange for the cashless exercise of warrants to purchase 505,661 shares of common stock	`OtherSignificantNoncashTransactionValueOfConsiderationGiven1`	$2.15M	USD	2 Qtrs
Issuance of 399,629 shares of common stock in exchange for the cashless exercise of warrants to purchase 505,661 shares of common stock	`OtherSignificantNoncashTransactionValueOfConsiderationGiven1`	-	USD	2 Qtrs

Stockholders Equity 23 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquity`	$8.30M	USD	Point-in-time
Balance	`StockholdersEquity`	$56.72M	USD	Point-in-time
Balance	`StockholdersEquity`	$14.37M	USD	Point-in-time
Stock compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$1.46M	USD	2 Qtrs
Stock compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$2.48M	USD	Annual
Exercise of warrants	`StockIssuedDuringPeriodValueOther`	$151.98K	USD	2 Qtrs
Exercise of warrants	`StockIssuedDuringPeriodValueOther`	$87.51K	USD	Annual
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$12.50K	USD	Annual
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$2.50M	USD	2 Qtrs
Exercise of stock options (in Shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	381,718.00	shares	2 Qtrs
Issuance of restricted stock	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	$763.97K	USD	2 Qtrs
Issuance of restricted stock	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	$228.16K	USD	Annual
Issuance of common stock, net of issuance costs	`StockIssuedDuringPeriodValueNewIssues`	$12.27M	USD	Annual
Issuance of common stock, net of issuance costs	`StockIssuedDuringPeriodValueNewIssues`	$41.22M	USD	2 Qtrs
Issuance of common stock, net of issuance costs (in Shares)	`StockIssuedDuringPeriodSharesNewIssues`	1.37M	shares	2 Qtrs
Net loss	`NetIncomeLoss`	$-9.02M	USD	Annual
Net loss	`NetIncomeLoss`	$-2.04M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-3.75M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-4.08M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-4.70M	USD	1 Quarter
Balance	`StockholdersEquity`	$56.72M	USD	Point-in-time
Balance	`StockholdersEquity`	$8.30M	USD	Point-in-time
Balance	`StockholdersEquity`	$14.37M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.